PCI Biotech Holding ASA (OSL:PCIB)
Norway · Delayed Price · Currency is NOK 0.2270
-0.0120 (-5.02%)
Jan 13, 2026, 3:00 PM CET
PCI Biotech Holding ASA Market Cap
PCI Biotech Holding ASA has a market cap or net worth of 8.47 million as of January 13, 2026. Its market cap has decreased by -82.80% in one year.
Market Cap
8.47M
Enterprise Value
-4.86M
Revenue
4.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.23
Market Cap Chart
Since June 23, 2008, PCI Biotech Holding ASA's market cap has decreased from 97.50M to 8.47M, a decrease of -91.31%. That is a compound annual growth rate of -12.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 8.47M | -7.72% |
| Dec 30, 2025 | 9.18M | -79.29% |
| Dec 30, 2024 | 44.34M | -43.29% |
| Dec 29, 2023 | 78.20M | 2.20% |
| Dec 30, 2022 | 76.52M | -85.26% |
| Dec 30, 2021 | 519.21M | -50.14% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.55B |
| Nordhealth AS | 2.77B |
| Photocure ASA | 2.06B |
| Thor Medical ASA | 1.81B |
| ArcticZymes Technologies ASA | 1.18B |
| Omda AS | 963.86M |
| Vistin Pharma ASA | 922.37M |
| Gentian Diagnostics ASA | 885.24M |